Brett R Hagen insider trades

Open-market stock purchases and sales by Brett R Hagen, Chief Accounting Officer at Kalaris Therapeutics, Inc, from SEC Form 4 filings since Aug 4, 2016.

Recent trades

DateStockTradeValue
Mar 20, 2026KLRS Kalaris Therapeutics, IncSold$12.9K
Mar 19, 2026KLRS Kalaris Therapeutics, IncBought (not open market)—

Companies traded

  • KLRS Kalaris Therapeutics, Inc: 2 sales, last Mar 20, 2026
  • ALVR Allovir, Inc: 54 sales, last Feb 21, 2025
  • PTI Proteostasis Therapeutics, Inc: other filings, last Apr 3, 2017

Get free alerts when Brett R Hagen files a new trade →